Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
128 * | Mon, 8/4/2014, 8:30 AM - 10:20 AM | CC-258B | |
Statistical Methods for Early Stopping and Go/No-Go Decision — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): Lihan Yan, FDA | |||
8:35 AM | Properties of Covariate-Adjusted Response-Adaptive Designs with Early Stopping — Yaping Wang, University of Texas Health Science Center at Houston ; Jack Lee, MD Anderson Cancer Center ; Hongjian Zhu, University of Texas School of Public Health | ||
8:50 AM | Group-Sequential Strategies When Considering Multiple Binary Outcomes as Co-Primary Endpoints — Toshimitsu Hamasaki, Osaka University Graduate School of Medicine ; Koko Asakura, Osaka University ; Scott R. Evans, Harvard School of Public Health | ||
9:05 AM | Comparison Between Adaptive Designs for Bio-Equivalence Study — Shuai Yuan, Merck ; Fang Liu, Merck ; Jialin Xu, Merck | ||
9:20 AM | Predictive Approach in Group Sequential Design for Time-to-Event Endpoint — Soumi Lahiri, Novartis ; Satrajit Roy Choudhury, Novartis | ||
9:35 AM | Futility Monitoring with Conditional Power: A Rationale for the Choice of Theta Assumption Based on Type II Error Probability — Thomas Dobbins, Merck | ||
9:50 AM | Continuous Covariate Imbalance and Conditional Power for Clinical Trial Interim Analyzes — Jody Ciolino, Northwestern University ; Renee' Martin, Medical University of South Carolina ; Wenle Zhao, Medical University of South Carolina ; Edward Jauch, Medical University of South Carolina ; Michael Hill, University of Calgary ; Yuko Palesch, Medical University of South Carolina | ||
10:05 AM | Single-Arm Two-Stage Phase 2 Clinical Trials with Go/No-Go/Grey-Zone Outcomes — Bob Zhong, Johnson & Johnson |
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.